An increasing number of closed-loop blood glucose (BG) control algorithms have been developed in recent years with the arti cial pancreas as the ultimate goal, although tight postprandial BG control remains an elusive goal. In this report, the authors propose a novel semi closed-loop BG control algorithm with meal announcement, which involves computation of the optimal continuous subcutaneous insulin infusion for a speci c meal 60 min prior to mealtime. It utilizes a mathematical model of glucose-insulin metabolism to predict the impact of carbohydrates on postprandial BG levels based on carbohydrate intake and glycemic index (GI) value. The optimal pre-meal insulin is infused until mealtime, after which the control algorithm switches to model predictive control (MPC) to stabilize postprandial glycemia at the target value of 100 mg/dL (5.55 mmol/L). In silico results for four representative foods with GI values spanning a wide range show that in the case of exact patient-model match with precise information of carbohydrate composition and mealtime, postprandial BG levels can be maintained between 86-134 mg/dL (4.78-7.44 mmol/L) and 86-152 mg/dL (4.78-8.44 mmol/L) for 50 g and 100 g of carbohydrates, respectively. With consideration of intra-patient variability and meal-related uncertainties regarding the estimated carbohydrate amount and start of meal consumption, the BG control range is 75-159 mg/dL (4.17-8.83 mmol/L) with no critical hypoglycemic episodes.
Introduction
Type 1 diabetes (T1D) is one of several forms of diabetes caused speci cally by an abrupt decline in endogenous insulin secretion from pancreatic β-cells, resulting in extremely high blood glucose (BG) levels. To prevent life-threatening complications in the long term, T1D patients must undergo a basal-bolus insulin therapy that requires an accurate estimation of the single-bolus insulin dose based on the total carbohydrate intake at every single meal. Despite continuous development of correction factors to increase the accuracy of estimation of prandial insulin needs [1] , T1D patients still not only suffer from postprandial hyper-and/or hypoglycemic episodes-with their respective accompanying symptoms-due to insulin bolus miscalculation, but also are constantly exposed to wide post-meal glycemic excursions that compromise endothelial function and directly impacts microvascular complications [2] . Thus postprandial hyperglycemia has been recently acknowledged to have a more deleterious effect on the overall management of diabetes than fasting BG levels [3] .
To reduce the burden of T1D treatment, there has been an increasing number of studies on automatic BG control systems aiming at the development of the arti cial pancreas [4] . Proportional-integral-derivative control [5] and model predictive control (MPC) [6] are the most widely utilized algorithms for BG control purposes, with different approaches being constantly proposed, including fully closed-loop control algorithms with automatic meal detection based on changes in BG levels [7] and semi closed-loop systems with improved postprandial BG control performance at the expense of additional input from the patient for an intended meal (meal announcement) [8] . Others favor a xed pre-meal bolus of 2 IU [9] or over-bolus [10] along with closedloop BG control, while a recent intraperitoneal insulin infusion [11] offers an interesting alternative to subcutaneous route due to faster insulin responses. Although these approaches in diurnal BG control have been shown to maintain postprandial BG excursion largely within a speci c range, they have not achieved the target maximum peak BG levels below 180 mg/dL (10.0 mmol/L) recommended by the American Diabetes Association (ADA) for prandial BG management in T1D patients [12] . These previous clinical results seem to indicate that tight diurnal BG control might be an unattainable goal, which is arguably attributed to the great plasma glucose appearance from carbohydrate-rich meals, combined with slow insulin absorption kinetics and delayed effect on BG levels of subcutaneous administration by up to several times compared to normal endogenous insulin secretion in nondiabetics.
Based on observation in clinical studies in which insulin bolus given 15 min prior to meal consumption reduced postprandial glycemic excursion [13] , the authors previously developed a prandial control algorithm that satisfactorily maintained postprandial BG levels within the recommended clinical range, by combining a pre-meal single insulin bolus with postprandial closed-loop BG control initiated at mealtime [14] to compensate for the rapid and large glycemic increase after a meal. Such BG control algorithm utilizes a novel mathematical model of glucose-insulin metabolism in T1D [15, 16] , which uses the amount of carbohydrates as well as the glycemic index (GI) [17] to accurately predict the glucose absorption rate according to the type of carbohydrate consumed and the impact on postprandial BG level.
Because of the limited performance of previous BG control algorithms during postprandial state, the present study seeks to determine the degree of attainability of tight prandial BG control in T1D in silico. In this way, provided meal announcement information of carbohydrate amount and GI value of the intended meal, the optimal continuous subcutaneous insulin infusion is determined from an insulin optimization problem computed at the initial time, and accordingly infused to the patient until mealtime. Thence, closed-loop MPC control is used for the following 440 min (> 7 hours) post-meal to ensure complete stabilization of BG level at the target value of 100 mg/dL (5.55 mmol/L) for the assessment of the BG control performance for different GI foods, as well as patient and food-related uncertainties.
The present article includes an elaborate description of the prandial BG control algorithm in Section 2, an in silico evaluation of BG control performance in Section 3, followed by further discussions of the results in Section 4, and conclusions in Section 5.
Method

Blood Glucose Control Strategy
In the present study, we use discrete-time control systems with sampling period Δt and discrete time step k, where t = kΔt. Utilizing the mathematical model developed in a previous study (see supplementary material) [15, 16] , the novel control algorithm proposed in the present section is detailed as follows. First, let k food be de ned as mealtime for the T1D patient, where k food = 0 is the initially intended mealtime. From this, let k i (< 0) be de ned as the initial time of prandial BG control and potential start of preprandial insulin infusion; and let k f (> 0) be the ending time in prandial BG control at which BG levels are completely stabilized at the target value (Fig. 1) . The purpose of the present control is to maintain prandial BG levels within those recommended by the ADA ( Table 1 ), Provided that k food = 0, the control strategy in the present study is divided into two parts. Initially, optimal preprandial insulin infusion to maintain tight BG control throughout the prandial state from k = k i to k f is computed at k = k i , although insulin is effectively infused only from k = k i to 0 (mealtime). Thereafter, the control algorithm automatically switches to closed-loop BG control utilizing MPC for stabilization and maintenance of BG levels at the target BG value until the nal time of k = k f . At mealtime, a single-meal is represented by an impulse signal in the input G food (t) with speci c carbohydrate intake in the input of the T1D patient model given by Eq. (S2) in the supplementary material.
Prandial Insulin Optimization
At the initial time k i , the optimal prandial insulin infusion is calculated by the cost function given by
where 
The prandial optimization problem is thus minimize
where U pre and U post are the maximum preprandial and postprandial insulin infusions, respectively, allowed for patient safety to avoid over-insulinization. Note that although the optimal insulin for 0 ≤ k ≤ k f is also computed in Eq. (3), only preprandial bolus insulin from k i to 0 is actually infused to the patient.
Postprandial BG control algorithm
After the total optimal insulin is computed according to Eq. (3) and effectively infused to the T1D patient until k = 0, the control algorithm switches to closed-loop BG control based on an MPC algorithm with cost function given by
where the weighting matrix Q(e) also follows Eq. (2) . N 1 and N 2 de ne the prediction horizon; N u is the control horizon; and e(k
is BG deviation of the model prediction from the reference trajectory given by
with convergence rate constant 0 < α < 1 and reference trajectory span of i = N 1 ,..., N 2 . In particular, the reference trajectory in Eq. (5) is an exponential curve for smoother approach of BG to- (1) At k = k i , optimal prandial insulin infusion from k = k i to k f is calculated from meal content information (amount and type of carbohydrate), and infused accordingly from k i to 0 (mealtime). (2) At k = 0, the control algorithm switches to MPC to maintain BG levels at the target value. 
from which the optimal postprandial insulin infusion is iteratively computed by evaluation of J MPC (k) and respective insulin infusion to the patient at each step from k = 0 until the end of the prandial state at k = k f .
Clinically relevant control parameters
Parameter settings of the present control algorithm take into consideration clinical requirements for BG control application. Due to the rapid BG uctuation from meal-derived glucose appearance, we consider Δt = 1 min adequate as commonly used in clinical studies [7, 18] . Start of preprandial insulin infusion is set at k i = − 60 to provide suf cient margin for the computation of the optimal preprandial insulin infusion and k f = 440 to guarantee complete stabilization of late postprandial BG levels. Target BG level is set at W R = 100 mg/dL (5.55 mmol/L) according to the ADA clinical recommendations. To prevent insulin overdosing, maximum preprandial insulin infusion rate is set at U pre = 2 IU/ min considering that the insulin bolus required (including differences in insulin-to-carbohydrate ratio) for a regular meal ranges from 3.7 to 10.9 IU [19] , whereas maximum postprandial insulin infusion rate is set at U post = 0.05 IU/min, which although considerably above basal pro les [20] , is considered adequate since it includes not only basal insulin needs but also residual prandial insulin needs, especially for foods with low GI. Tuning parameters for the prandial control algorithm are Q = 1, Q LO = 10, R = 111, N 1 = 40 steps, N 2 = 130 steps, N u = 1, and α = 0.995, such that the control algorithm satis es the ADA clinical recommendations for prandial BG management ( Table 1 ). In particular, the values of N 1 and N 2 are set to include the maximum hypoglycemic effect of insulin, which occurs between 1-2 hours after infusion, and the unitary value in N u for increased robustness in the control system against errors [21].
Simulation
In order to assess the effectiveness of the proposed prandial BG control algorithm, we perform BG control simulations in MAT-LAB® for varying amounts of carbohydrate-rich foods with a wide range of GI (values in parenthesis); instant potato (83), white bread (71), spaghetti (41) and pearled barley (25). First, for the nominal case, the BG control algorithm is assessed for carbohydrate loads of 50 g and 100 g with exact model-patient match and mealtime in the T1D patient model at k food = 0. Second, intra-patient variability due to continuous subcutaneous same-tissue utilization [22] and differences in reproducibility of the GI value of a meal [23] are also considered, incorporating ±20% variation in insulin-dependent glucose uptake (i.e., insulin sensitivity), parameter p 3 of the T1D patient model, and GI value of the food as given in Eqs. (1) and (14) in the supplementary material. Lastly, food-related uncertainties commonly found in real-life scenarios include misestimation of carbohydrate intake of ±10 g (20%) from the nominal amount of 50 g and deviation in mealtime (k food = ±15 min) in the continuous-time T1D patient model, considering that the assumed mealtime in the controller remains xed at 0. Initial parameter values for all simulations are set at fasting state with basal insulin infusion to maintain BG levels at 100 mg/dL. In particular, the function fmincon is utilized exclusively for computation of the cost function in Eq. (3).
Results
Results of the three aforementioned cases examined in the simulation study are presented in the following subsections.
Nominal case
We assess the performance of the present BG control algorithm for 50 g of the aforementioned carbohydrate-rich foods with GI values as shown in Fig. 2 . The optimal preprandial bolus and postprandial basal insulin infusions are shown separately in Figs. 3 and 4. In particular, Fig. 3 shows that the optimal preprandial bolus insulin follows a hill-shaped infusion pattern with (126) large differences in peak bolus insulin infusion and timing among the representative carbohydrate-rich foods. Note that only the optimal preprandial insulin from k i to 0 is infused to the T1D patient, although the optimization in Eq. (1) computes the total prandial insulin requirement from k i through k f . For exact comparison, the range in BG excursion for each type of food is also given in Table 2. There are de nite differences in BG control response between high and low GI foods. BG is maintained close to ideal values for foods with lower GI values, whereas postprandial glycemia is observed with peaks within the ADA recommended value for foods with higher GI values. Additionally, we examine the response of the prandial BG control algorithm for a larger carbohydrate load of 100 g, and the prandial BG control ranges are shown in Table 2 . For each food, BG levels are also maintained within similar values as those for a 50-g load with the same GI value, with equally similar insulin infusion pattern depending on the GI value.
Intra-individual variability
Simulation results considering intra-individual variation of parameter p 3 ± 20% and GI ± 20% in the patient model for a high GI food (instant potato) are shown in Fig. 5 . The results indicate that BG levels can be effectively maintained within the ADA recommended values. Slower meal-derived glucose appearance from low GI foods contributes to less pronounced BG excursions directly proportional to the GI value of the food ( Table 2 ).
Food-related uncertainties
Simulation results of food-related uncertainties in mealtime and carbohydrate estimation for a high GI food (instant potato) are shown in Fig. 6 , and the BG control ranges for the four representative foods are given in Table 2 . Even though postprandial glycemic excursion is maintained below 160 mg/dL (8.89 mmol/L) in all cases, there is a risk of borderline hypoglycemia with BG level reaching 75 mg/dL (4.17 mmol/L) between 20-30 min due to delayed mealtime, and 79 mg/dL (4.39 mmol/L) between 190-220 min caused by early mealtime combined with a 10-g underestimation of carbohydrate intake.
Discussion
This study presents an in silico evaluation of a semi closed-loop BG control algorithm for prandial state with prior meal announcement, which consists of preprandial insulin bolus infusion com- puted 60 min prior to the intended mealtime, followed by postprandial closed-loop control to maintain BG levels at the target value of 100 mg/dL as recommended by the ADA. Compared to our previous work [14] which was limited to an instantaneous single-bolus administered at a speci c instant between k i = − 30 and 0 (i.e., single-bolus administration at a speci c instant between 30 min prior to mealtime and 0 min), the present study considers continuous variable insulin infusion instead and the potential of starting insulin infusion from k i = − 60 in order to obtain the optimal preprandial bolus dose and timing for each speci c type of food. This study also extends the time span in the cost function to include the total prandial state from k i to k f . Moreover, the mathematical model utilized is an enhanced version of the model employed in our previous study [14] . It includes the maximum rate of glucose appearance from carbohydrates [16] to provide a more accurate model-based prediction of postprandial BG excursion in the present study. For a more thorough assessment of the performance of the BG control algorithm, we not only consider the nominal case as in our previous study [14] but also examine variability in subcutaneous insulin absorption as well as uncertainties in food amount and mealtime in the T1D patient model. Considering that daytime hypoglycemia (BG levels below 60 mg/ dL) in T1D patients has a negative impact on the quality of life and health care cost even for mild episodes [24], the above improvements are necessary to prevent the risk of late postprandial hypoglycemia due to the remnant hypoglycemic effect of insulin several hours after large preprandial bolus doses. In addition, computation of maximum doses for preprandial and postprandial insulin infusions (U pre = 2 IU/min and U post = 0.05 IU/min) are necessary for safety reasons. In particular, U post is noticeably above the maximum basal insulin infusion in closed-loop clinical trials [25] . Yet, this dose is considered necessary since slow digestion and absorption of low GI foods require greater insulin infusion rates than the basal rate for as long as 200 min post-meal. Note that the utilization of U pre and U post does not affect noticeably the performance of the control algorithm for any of the simulations cases examined in this study. To our knowledge, the present study demonstrates for the rst time the feasibility of tight prandial BG control in patients with T1D even beyond ADA recommendations, although at the expense of starting prandial insulin infusion approximately 50 min before meal, which is arguably not a practical value for the operation of an arti cial pancreas system in everyday conditions. Furthermore, the post-meal glycemic excursions in the simulation results, which are proportional to the GI values of the foods, are identical to those observed in nondiabetics for similar GI values [26] . This nding indicates that the BG control results obtained in the present study are comparable to the ideal response in healthy subjects. Nevertheless, the apparent inability of the present control algorithm to obtain a completely at BG response for high GI foods-as represented by instant potato-compared to medium and low GI foods actually demonstrates the extent at which tight BG control is feasible under ideal conditions. Moreover, the insulin infusion patterns for nominal carbohydrate intakes of 50 g and 100 g indicate that the GI of the food is more relevant than the total intake in determining the infusion pattern, whereas carbohydrate intake only impacts the preprandial insulin dosage. This is consistent with reports from recent clinical studies that emphasize the dif culty in determining an appropriate bolus infusion pattern for a speci c meal [27] despite the availability of insulin pump technologies with several bolus infusion patterns. It is also interesting that despite all the foods having an identical carbohydrate content of 50 g, the start of preprandial insulin infusion and the total bolus required differ proportionally to the GI value (Fig. 3) , which is supports prior clinical studies [28] suggesting that the current insulin bolus estimation from carbohydrate intake alone should be extended to include the GI value.
Assessment of the present control algorithm beyond the nominal case includes patient-model mismatch (individual variability) and food-related uncertainties. In particular, since parameters of the mathematical model of glucose-insulin metabolism in T1D are assumed to have a good t for a representative patient, only intra-patient variability is considered as a source of model mismatch. Simulation results not only show that the control algorithm effectively maintains BG levels within the ADA recommended clinical values, but also that spontaneous patient variability regarding insulin sensitivity and glycemic impact of the food, as well as food-related uncertainties in both amount and timing can be managed within a BG peak below 160 mg/dL (8.89 mmol/L) and a nadir of 75 mg/dL (4.16 mmol/L) in all cases. Although the duration of meal consumption-and consequently impact on BG levels-in the T1D patient model might vary among individuals, the mathematical model previously developed (supplementary material) has been validated by clinical studies in which patients explicitly consumed the meal within 10 min. Hence, differences in postprandial BG excursion due to the meal consumption time are considered to be less relevant than intra-individual variability and food-related uncertainties examined in the present study for assessing the performance of the BG control algorithm.
Previous studies employing bi-hormonal closed-loop BG control systems with both insulin and glucagon infusions [29, 30] utilize the latter to prevent postprandial hypoglycemia, although such approach is known to increase both the complexity of the control system and burden to the patient due to the requirement of additional glucagon infusion. Compared to this, the control algorithm proposed in the present study considers the glycemic im- 
pact of different types of carbohydrates-as represented by their GI values-for more accurate BG prediction and early insulin infusion as a countermeasure against the well-known delay in subcutaneous absorption. As a result of this proactive approach, the maintenance of BG levels above 75 mg/dL (Table 2) suggests that an additional algorithm for glucagon infusion might not be necessary for successful diurnal BG control. It should be noted, though, that even with such prediction capabilities, the present control algorithm does not consider insulin-on-board, i.e., residual insulin active for as long as 4-5 hours in the case of rapid-acting insulin, and thus entails a risk of postprandial hypoglycemia in the case of successive meals with few hours in-between. Although the cost function includes a penalty term Q LO to reduce the risk of hypoglycemia, we believe that the BG impact from successive meals and the overlapped effect of the respective prandial insulin infusions might require more meticulous consideration of the control algorithm law, as well as the case of unplanned additional food or nibbling through a longer time span as in typical real-life scenarios. Nevertheless, due to the satisfactory in silico results achieved in the present study, further clinical implementation might be eventually considered, which would provide more strict evaluations of hypoglycemic risk for patient safety and methods to curtail the time of preprandial insulin infusion for practical reasons,.
Conclusion
In the present study, the feasibility of a BG control algorithm that maintains tight BG control during prandial state even beyond ADA recommendations was demonstrated in silico. The total carbohydrate intake and GI value of the food are used in the computation of the optimal prandial insulin infusion under an ideal setting. Tight postprandial BG control is achieved by insulin infusion from 60 min prior to the intended mealtime in combination with closed-loop postprandial BG control based on MPC. Simulation results of the control algorithm proposed in this study show satisfactory performance not only for nominal carbohydrate loads of 50 g and 100 g but also with considerations of intra-individual variability and uncertainties in actual carbohydrate intake and mealtime. 
Supplementary Material
Mathematical Model of glucose-insulin metabolism
We have proposed a mathematical model of glucose-insulin metabolism in T1D [15, 16] , which represents a) carbohydrate digestion and absorption, b) subcutaneous insulin pharmacodynamics and c) glucose-insulin metabolism. In particular, carbohydrate digestion and absorption (Fig. S1) consider carbohydrate intake and the GI value to derive the glucose-equivalent amount (GR), and further divided into rapidly (RAG) and slowly (SAG) available glucose according to the Englyst method. Table S1 lists the variables and parameters of the mathematic model. the main model equations are given by
Diagram of carbohydrate digestion and absorption as glucose-equivalent (GR) amount from carbohydrate intake and GI value, which is further divided into rapidly and slowly available glucose (RAG and SAG). Physiological considerations of maximum absorption rate of meal-derived glucose appearance Ra max and delay in gastric emptying ( rst order delay) are also included. 
d dt
where G food (t) is the meal input signal of the model, t food is the total food ingestion period, and further matrix representation of RAG and SAG absorption is given by G RAG (t) = C R x R (t) (S6) G SAG (t) = C S x S (t − τ SAG ) (S7) G RAG (t) and G SAG (t) represent RAG and SAG absorption, respectively, with C R = C S = [1 0], and τ SAG = 20 min for delay of SAG absorption by de nition. Maximum rate of meal-derived exogenous glucose appearance (Ra max ) followed by food-speci c delay in gastric emptying [G ext (t)] are also considered as
with time parameters t 1 , t 2 and t 3 being speci c to the amount and GI value of the food. Subcutaneous rapid-acting insulin absorption kinetics from Shimoda et al. [5] is given by dx 1 (t) dt = −k 21 x 1 (t) + u s (t) (S10)
Lastly, the glucose-insulin metabolism subsystem from Bergman minimal model [6] comprises dG(t) dt = −X(t)G(t) + p 1 (G b − G(t)) + G ext (t) V 1 (S13)
Parameter values of a representative patient with T1D, as well as carbohydrate absorption parameters for four representative staple foods are further detailed elsewhere [15, 16] . 
